debabrata
●    

2005-10-19 08:58
(6320 d 14:10 ago)

Posting: # 42
Views: 20,548
 

 Investigational Products for BA/BE [Regulatives / Guidelines]

According to Canadian Regulatory requirement, what is the retention sample quantity that has to be kept in the CRO after completion of the study? Also what is the retention period?
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2005-10-19 13:22
(6320 d 09:46 ago)

@ debabrata
Posting: # 43
Views: 19,416
 

 Investigational Products for BA/BE

Hi!

'Preparation of Comparative Bioavailability Information for Drug Submissions in the CTD Format' (Draft Guidance, 2004-05-12) states:

Retention of Samples
It is recommended that samples of the test and reference drug products used in the comparative bioavailability study(ies), and the biological samples collected, including QC samples, be retained until the submission is either cleared or withdrawn.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
debabrata
●    

2005-10-20 09:22
(6319 d 13:46 ago)

@ debabrata
Posting: # 44
Views: 15,837
 

 Investigational Products for BA/BE

❝ According to Canadian Regulatory requirement, what is the retention sample quantity that has to be kept in the CRO after completion of the study? Also what is the retention period?


Is there any specific retention quantity that has to be kept in the CRO like US FDA?
H_Rotter
★    

Germany,
2005-10-20 17:43
(6319 d 05:25 ago)

@ debabrata
Posting: # 45
Views: 15,629
 

 Investigational Products for BA/BE

I don't think so; have you considered asking HPFB?

Regards,
Hermann
UA Flag
Activity
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
21 visitors (0 registered, 21 guests [including 7 identified bots]).
Forum time: 22:08 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5